Induction Outcome Among Children With and Without Down Syndrome
| . | DS . | No DS . | DS/No DS P Value . | ||
|---|---|---|---|---|---|
| N . | (%) . | N . | (%) . | ||
| Standard timing | 85 | (100) | 300 | (100) | |
| Fail | 2 | (2) | 67 | (22) | <.001 |
| Die | 2 | (2) | 14 | (5) | .525 |
| CR | 81 | (95) | 219 | (73) | <.001 |
| Intensive Timing | 25 | (100) | 652 | (100) | |
| Fail | 1 | (4) | 65 | (10) | .520 |
| Die | 8 | (32) | 69 | (11) | .003 |
| CR | 16 | (64) | 518 | (79) | .108 |
| . | DS . | No DS . | DS/No DS P Value . | ||
|---|---|---|---|---|---|
| N . | (%) . | N . | (%) . | ||
| Standard timing | 85 | (100) | 300 | (100) | |
| Fail | 2 | (2) | 67 | (22) | <.001 |
| Die | 2 | (2) | 14 | (5) | .525 |
| CR | 81 | (95) | 219 | (73) | <.001 |
| Intensive Timing | 25 | (100) | 652 | (100) | |
| Fail | 1 | (4) | 65 | (10) | .520 |
| Die | 8 | (32) | 69 | (11) | .003 |
| CR | 16 | (64) | 518 | (79) | .108 |
Excludes 130 patients with indeterminate outcome and 14 who switched induction therapy from standard to intensive timing midcourse when intensive timing was determined to be the superior regimen.